Invasive Pneumococcal Disease (IPD)

Download Report

Transcript Invasive Pneumococcal Disease (IPD)

Invasive Pneumococcal
Disease (IPD)-2010
Veerinder (Vinny) Taneja
PHIN Coordinator
CEDS
TN-DOH
[email protected]
Background
 List of Nationally Notifiable Infectious
Disease Conditions is updated
periodically
– Additions/Deletions
 Emerging Pathogens or decreasing incidence
– State-CDC-CSTE collaboration
2010 Changes for IPD
 All cases of invasive pneumococcal disease
should be reported using a SINGLE condition:
– Streptococcus pneumoniae, invasive disease (IPD) (all
ages)
 The classification of invasive pneumococcal
disease cases into two separate conditions should
be discontinued
– Streptococcus pneumoniae, drug resistant, invasive
(DRSP)
– Streptococcus pneumoniae, invasive
Changes to NBS
 NBS was recently upgraded to version 3.1.1
on 03/19/2010
– All 3 conditions are now available in NBS under the Select
Condition drop down
Changes to NBS- IPD
 2 of the old conditions will soon be disabled
 Changes to case definition
– Confirmed: Isolation of Streptococcus
pneumoniae from a normally sterile body site in
a person of any age.
 Disease manual update and updated
reportable conditions list
– Provider education about reporting IPD and
antibiotic testing results
NBS data entry changes
 Leave all previously entered 2010 cases as
is (MAKE NO CHANGES)
 Enter all new cases of Invasive
Pneumococcal Disease as
– Streptococcus Pneumoniae, Invasive Disease (IPD)
 Enter Antimicrobial Resistance Testing
Results
Antimicrobial Resistance Testing
Results
Recommended Antibiotic Results
 The antibiograms for S. pneumo are
recommended to include the following:
–
–
–
–
–
–
ceftriaxone
erythromycin or clindamycin
levofloxacin
penicillin
tetracycline
meropenem
DRSP is defined as resistance to one or more of
the antibiotics commonly used to treat Strep
Pneumo.
Data Analysis
 For years 2009 and prior the two old
conditions will be used
 For 2010 all three conditions will be used
 For 2011 the new IPD condition will be used
– Stratify by resistant and sensitive
References
 National Notifiable Diseases Surveillance
System
http://www.cdc.gov/ncphi/disss/nndss/nndsshis.htm
 CSTE Position Statement Number:
09-ID-06
http://www.cste.org/ps2009/09-ID-06.pdf